What is Benchmark's gross profit margin?

What were the key takeaways from Benchmark's earnings call?

What is Benchmark's latest dividend and current dividend yield?

What factors drove the changes in Benchmark's revenue and profit?

Did Benchmark beat or miss consensus estimates last quarter?

What were the key takeaways from Benchmark’s earnings call?

What guidance did Benchmark's management provide for the next earnings period?

What does Benchmark do and what are its main business segments?

- **Q4 Strong Execution**: $704M revenue (+7% YoY), $0.71 EPS beat, 10.6% gross margin.
- **Sector Momentum**: Medical +23% YoY, AC&C AI wins drive 2026 growth.
- **Semi-Cap Recovery**: 2026H1 recovery expected, Semi-Cap +2% YoY in 2025.
- **Cash Flow Strength**: $85M free cash flow, 22-day improvement in cash conversion cycle.
- **Leadership Transition**: David Moezidis to lead, with focus on 2026+ growth in space, med tech, and AI.

**【CEO Summary Section】**
- Q4 2025 revenue of $704 million (+7% YoY), with 3 of 5 sectors (AC&C, Medical, A&D) growing double digits.
- Non-GAAP EPS of $0.71 exceeded guidance, driven by 10.6% gross margin and 5.5% operating margin.
- Full-year 2025 revenue of $2.66 billion flat YoY, but with sequential growth and 5% EPS growth.
- Key wins in space, med tech, and AI; Semi-Cap recovery expected in 2026.

**【CFO Financial Commentary】**
- Q4 2025: GAAP net income $42.3 million, Non-GAAP EPS $0.71 (+14% YoY). Full-year 2025 free cash flow $85 million.
- Semi-Cap Q4 revenue down 8% QoQ but full-year +2%; A&D up 17% YoY, Medical +23% YoY.
- Q1 2026 guidance: Revenue $655-695 million (+7% YoY), Non-GAAP EPS $0.53-0.59.
- 2025 cash conversion cycle improved 22 days YoY to 67 days.

**【President's Sector Outlook】**
- **Semi-Cap**: Recovery expected in 2026H1, with new wins and Penang facility expansion.
- **Medical**: Q4 +14% QoQ, 2026 growth driven by med device and life sciences wins.
- **AC&C**: Q4 +22% QoQ, AI-related wins to drive 2026H1 growth.
- **A&D**: 2025 +19% YoY, space program ramps to accelerate in 2027.
- **Industrial**: 2025 flat YoY but improving macro backdrop.

**【Q&A Highlights】**
- **Semi-Cap Recovery**: Early signs of 2026H1 recovery, orders being pulled forward.
- **Margins**: Gross margin stable at ~10.5%, operating leverage to drive EPS growth.
- **Space Growth**: 2025 bookings to ramp in 2026-2027, contributing to A&D growth.
- **CapEx**: 2-2.5% of revenue for 2026, focused on Penang expansion and new program wins.
- **CEO Transition**: David Moezidis to lead, with confidence in 2026+ growth trajectory.

Benchmark Electronics, Inc. (BHE) Q4 2025 Earnings Call Transcript

- **Revenue Beat**: Q3 revenue of $681 million (+6% QoQ, +15% AC&C YoY) with non-GAAP EPS of $0.62, driven by medical (18% YoY) and A&D (26% YoY) growth.
- **AI & HPC Momentum**: 2026H2 AI/enterprise AI ramp expected, with HPC builds supporting 2026 growth. Semi-cap recovery signals for 2026H2.
- **Cash Flow Strength**: $25M free cash flow (Q3) and $74M LTM, with 77-day cash conversion cycle (down 13 YoY).
- **Medical Recovery**: 15% YoY growth, competitive takeaways, and medtech expansion driving 2026 continuity.
- **CapEx Outlook**: 2026 capex ~2% of revenue, focused on automation and growth programs.

**【CEO Summary Section】**
- **Revenue Growth**: Q3 2025 revenue of $681 million, up 6% sequentially and at the high end of guidance, with non-GAAP EPS of $0.62. This marks the eighth consecutive quarter of 10%+ gross margin.
- **Sector Momentum**: Double-digit growth in medical (18% YoY) and A&D (26% YoY), with sequential growth in 4 of 5 sectors. Semi-cap softened due to China restrictions and tariffs.
- **Cash Flow Strength**: Generated $25 million in free cash flow, totaling $74 million over 12 months. Investing in new PT4 building in Malaysia while maintaining 50% Americas manufacturing capacity.

**【CFO Financial Commentary】**
- **Q3 Financials**: GAAP net income of $42.3 million, with non-GAAP gross margin of 10.1% (down 10bps YoY). Operating margin improved to 4.8% due to revenue leverage.
- **Q4 Guidance**: Revenue $670-720 million (mid-single-digit YoY growth), non-GAAP EPS $0.62-0.68. Free cash flow expected to remain strong, with capex focused on automation and growth programs.
- **Liquidity**: Cash balance of $286 million, with $476 million available under revolver. Cash conversion cycle improved to 77 days (down 13 YoY).

**【CCO Sector Update】**
- **AC&C**: Sequential growth driven by AI and HPC wins, with Q4 ramp expected. 2026 outlook includes sovereign AI and enterprise opportunities.
- **Medical**: 15% YoY growth, with competitive takeaway wins and medtech subsector expansion. 2026 growth expected to continue as channel inventory normalizes.
- **A&D**: Double-digit YoY growth in space and defense, with significant satellite manufacturing wins. Semi-cap bookings remain strong despite near-term demand softness.

**【Q&A Highlights】**
- **AI/HPC Timeline**: Revenue ramp expected in mid-2026, with enterprise AI and sovereign projects driving growth. HPC builds will complement AI demand.
- **Semi-Cap Recovery**: 2026H2 outlook for demand pickup, supported by multiyear AI-related silicon content growth. Malaysia expansion positions for long-term wins.
- **Cash Management**: Inventory turns improved to 4.8x, with focus on maintaining cash flow discipline amid growth investments.


Benchmark Electronics, Inc. (BHE) Q3 2025 Earnings Call Transcript

- **Gross Margin Resilience**: 10.2% gross margin maintained, 7 straight quarters >10%.
- **Sector Strength**: A&D (+16% YoY), Medical sequential growth post-inventory correction.
- **AI/HPC Growth**: Liquid cooling wins in AC&C to drive Q4+ recovery.
- **Balance Sheet Health**: $265M cash, $134M share buyback capacity, debt refinanced to 2030.
- **Operational Efficiency**: 85-day cash cycle, 4.3 inventory turns (target 5-5.5).

**【CEO Summary Section】**
- Q2 2025 revenue of $642 million, with non-GAAP EPS of $0.55, both at midpoint of guidance.
- 7 consecutive quarters of >10% gross margin (10.2% in Q2).
- Sequential growth in 3 of 5 sectors; year-over-year growth in semi-cap (+11%) and A&D (+16%).
- Record bookings in medical and AC&C, with multiyear visibility.
- Debt refinanced at attractive rates; $152M cash repatriated from China/Thailand.

**【CFO Financial Commentary】**
- GAAP net income: $420M; non-GAAP EPS: $0.55 (vs. $0.52-$0.58 guidance).
- Gross margin: 10.2% (flat YoY, +10bps QoQ); operating margin: 4.7%.
- Free cash flow: -$15M in Q2 (due to one-time tax payments), but $80M+ trailing 12 months.
- Cash balance: $265M; $134M remaining under share repurchase program.

**【Sector Performance】**
- **Semi-Cap**: Double-digit YoY growth, but headwinds from trade restrictions.
- **A&D**: 16% YoY growth; strong bookings in satellite/space applications.
- **Medical**: Sequential growth after inventory correction; new competitive wins.
- **AC&C**: Flat QoQ, but AI/HPC liquid cooling wins expected to drive Q4+ growth.

**【Q&A Highlights】**
- **AC&C Recovery**: Liquid cooling expertise wins AI/HPC contracts; Aurora supercomputer deployment to ramp Q4.
- **Semi-Cap Outlook**: Outperforming market despite trade restrictions; $1T+ 2030 industry vision.
- **Medical Turnaround**: Inventory overhang cleared; new programs to contribute in 2026.
- **Cash Cycle**: 85 days (improved 5 days YoY); targeting 5-5.5 inventory turns.


Benchmark Electronics, Inc. (BHE) Q2 2025 Earnings Call Transcript

- **Semi-Cap Dominance**: 18% YoY growth driven by U.S. fab investments, offsetting China export headwinds. 
- **A&D Strength**: Defense programs boost A&D revenue 15% YoY, with 2025 growth expected. 
- **Cash Flow Resilience**: 8th consecutive quarter of positive free cash flow ($27M Q1), despite Q2 tax headwinds. 
- **H2 Growth Catalysts**: Medical recovery, AC&C program ramps, and industrial new bookings. 
- **Tax Efficiency**: Targeting 24-26% effective tax rate, with strategic initiatives to lower long-term burden. 
- **M&A Strategy**: Open to accretive tuck-in acquisitions, but focused on organic sector expansion. 


**【CEO Summary Section】**
- Q1 2025 revenue of $632 million, driven by 18% YoY growth in semi-cap and 15% YoY growth in A&D sectors. Non-GAAP EPS of $0.52 exceeded guidance midpoint. 
- Free cash flow of $27 million, with trailing 12-month total of $140 million. 6th consecutive quarter of >10% non-GAAP gross margin. 
- Semi-cap growth outpaces market due to share gains; A&D momentum from defense programs. U.S. manufacturing footprint (36%) positions for supply chain optimization amid tariffs. 
- Q2 outlook: Revenue $615-665M, non-GAAP EPS $0.52-0.58. Expect sequential growth in H2 2025, driven by medical recovery and AC&C program ramps. 

**【CFO Financial Commentary】**
- Q1 GAAP net income $420M, Non-GAAP EPS $1.08 (vs. $1.05 consensus). Non-GAAP gross margin 10.1%, down 30bps QoQ but +10bps YoY. 
- Operating cash flow $32M, free cash flow $27M. Cash balance $355M (up $59M YoY). Share buybacks $8M, $142M remaining under repurchase plan. 
- Q2 guidance: Non-GAAP gross margin 10.2-10.4%, operating margin 4.8-4.9%. Free cash flow impacted by $10M tax payment and $20M 2017 transition tax payment. 

**【Q&A Key Themes】**
- **Demand Environment**: Customers pausing shipments but also pulling forward products due to tariff uncertainty. Semi-cap growth tempered by China export restrictions but offset by U.S. fab demand. 
- **Industrial Sector**: Strong new bookings (+18% YoY) in digital displays and geospatial solutions, but revenue softness expected until Q4. 
- **Medical Recovery**: Channel inventory normalization and new program wins expected to drive 2H 2025 growth. 
- **Tax Strategy**: 2025 effective tax rate ~24-26%, targeting long-term reduction through strategic planning. 
- **M&A Activity**: Open to tuck-in acquisitions enhancing high-value add capabilities, but prioritizing organic growth. 

**【Operational Highlights】**
- Penang, Malaysia facility expansion underway, supporting semi-cap growth. 86-day cash conversion cycle (improved 3/8 days QoQ/YoY). 
- Global trade compliance team navigating complex tariff landscape, ensuring customer commitments. 
- Share buybacks and dividend payments reinforce capital return strategy. 


Benchmark Electronics (BHE)-29 Apr 25-2025 Q1 Earnings call transcript

- **Q4 2024 Performance**: Revenue $657M (flat QoQ, -5% YoY), Non-GAAP EPS $0.61 (beat $0.59 high end). Gross margin 10.4%, up 10 bps YoY. Free cash flow $46M.
- **2025 Outlook**: Semi-cap +10%+, medical flat, industrial +low single digits. New defense and medical wins drive long-term growth. 
- **Financial Highlights**: FY2024 Non-GAAP EPS $2.29, gross margin 10.2% (+70 bps YoY). Q1 2025 EPS guide $0.48-$0.54, CapEx $65M-$75M for new Malaysia facility.
- **Key Drivers**: Semi-cap share gains, defense program expansion, and cost control. Inventory optimization and new capacity to drive margin leverage.

**【CEO Summary Section】**
- Q4 2024 revenue of $657 million was in line with guidance, driven by strong semi-cap and industrial performance, offset by weakness in medical and AC&amp;C. Non-GAAP gross margin was 10.4%, up 10 bps YoY. Operating margin was 5.1%, down 20 bps sequentially due to variable compensation. 
- 2025 outlook: Double-digit growth in semi-cap, flat medical revenue, low-single-digit industrial growth. New wins in defense, space, and medical devices position for long-term growth. 
- Free cash flow of $46M in Q4 and $156M for FY2024 highlights operational efficiency. Share buybacks and dividend increases signal capital return focus.

**【CFO Financial Commentary】**
- FY2024 revenue $2.7B (-6% YoY), GAAP EPS $1.72, Non-GAAP EPS $2.29. Gross margin expanded 70 bps to 10.2% due to cost reductions and favorable mix. Operating margin 5.1%, up 20 bps YoY. 
- Q1 2025 guidance: Revenue $620M-$660M, Non-GAAP EPS $0.48-$0.54. Gross margin 10%-10.2%, SG&amp;A $34M-$36M. Free cash flow expected $50M-$80M, driven by $65M-$75M CapEx for new Malaysia facility.

**【Q&A Key Takeaways】**
- Semi-cap growth in 2025: 18% YoY in Q4 driven by share gains and new wins; 2025 growth to be 10%+ from demand recovery and ramping wins. 
- Working capital: Inventory turns improved to 4x from 5.5x; further optimization expected. 
- Margin leverage: New capacity in low-cost regions (Guadalajara, Romania, Penang) positions for utilization-driven margin expansion as demand recovers.


Benchmark Electronics (BHE)-29 Jan 25-2024 Q4 Earnings call transcript

Benchmark Electronics (BHE)-30 Oct 24-2024 Q3 Earnings call transcript

Benchmark Electronics (BHE)-30 Jul 24-2024 Q2 Earnings call transcript

Benchmark Electronics (BHE)-1 May 24-2024 Q1 Earnings call transcript

- **Revenue and Margin Growth**: Q4 non-GAAP gross margin expanded to 10.3%, with free cash flow of $126 million exceeding annual target. Semi-cap sector outperformed the industry.
- **Sector Challenges**: Medical and industrial sectors face demand softness, while next-gen communications sector is under pressure due to reduced capital spending.
- **Financial Outlook**: Q1 2024 guidance includes revenue of $625-$665 million and gross margin of 9.8%-10.2%, with a focus on inventory reduction and debt management.

**【CEO Summary Section】**
- Q4 revenue of $691 million, with non-GAAP gross margin of 10.3%, up 70 basis points year-over-year. Free cash flow of $126 million exceeded guidance, driving annual free cash flow of $97 million. Semi-cap sector outperformed the industry, while medical and industrial sectors faced demand softness. New wins in Mexico and automation highlight growth opportunities.

**【CFO Financial Commentary】**
- Non-GAAP EPS of $0.58 exceeded expectations. Q1 2024 guidance includes revenue of $625-$665 million, gross margin of 9.8%-10.2%, and free cash flow target of $70-$80 million. Effective tax rate expected to rise due to China tax holiday expiration and Pillar 2 regulations. Capital allocation focuses on debt reduction and share buybacks.

**【Q&A Highlights】**
- Medical and industrial sectors expected to remain soft in Q1, with inventory management a key focus. Semi-cap sector faces capital spending constraints but shows long-term growth potential. Gross margin sustainability tied to demand trends and cost management. Inventory reduction plans aim to maintain free cash flow momentum.

Actual										0.22	0.07	0.32	0.34	0.21	0.27	0.39	0.48	0.44	0.5	0.57	0.6	0.42	0.48	0.57	0.58	0.55	0.57	0.57	0.61	0.52	0.55	0.62	0.71
Forecast										0.1633	0.09	0.28	0.3333	0.1967	0.26	0.3833	0.4067	0.3433	0.41	0.5225	0.6025	0.4201	0.466	0.5225	0.5625	0.46	0.5075	0.5425	0.5615	0.5025	0.5425	0.5775	0.6425
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+34.72%	-22.22%	+14.29%	+2.01%	+6.76%	+3.85%	+1.75%	+18.02%	+28.17%	+21.95%	+9.09%	-0.41%	-0.02%	+3.00%	+9.09%	+3.11%	+19.57%	+12.32%	+5.07%	+8.64%	+3.48%	+1.38%	+7.36%	+10.51%

BHE

BHE fundamentals

BHE Q4 2025 Earnings

Earnings Call

You can ask Aime

BHE

BHE fundamentals

BHE Q4 2025 Earnings

Earnings Call

BHE Earnings Call Summary for Q4/20255:00 PM on Feb 3, 2026

BHE Earnings Call Summary for Q3/20255:00 PM on Nov 4, 2025

BHE Earnings Call Summary for Q2/20255:00 PM on Jul 30, 2025

BHE Earnings Call Summary for Q1/20255:00 PM on Apr 29, 2025

BHE Earnings Call Summary for Q4/20245:00 PM on Jan 29, 2025

You can ask Aime